TRIgnite-1

A Phase 1, First-in-Human, Multicenter, Open-Label, Dose Escalation and Dose-Expansion Study of Single-Agent ISB 2001 in Subjects With Relapsed/Refractory Multiple Myeloma

Near Add Your Location

Sorting 7 by

Medical College of Wisconsin
Froedtert Hospital
Milwaukee, WI
  • Accepting patients
University of Chicago Medicine
Comprehensive Cancer Center
Chicago, IL
  • Accepting patients
UNC Lineberger Comprehensive Cancer Center
University of North Carolina
Chapel Hill, NC
  • Accepting patients
Winship Cancer Institute
Emory University
Atlanta, GA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.